-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Oncology Institute, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2019 to Q3 2024.
- Oncology Institute, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
- Oncology Institute, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$314K, a 253% decline year-over-year.
- Oncology Institute, Inc. annual Income Tax Expense (Benefit) for 2023 was -$36K, a 85.2% increase from 2022.
- Oncology Institute, Inc. annual Income Tax Expense (Benefit) for 2022 was -$243K, a 63.8% increase from 2021.
- Oncology Institute, Inc. annual Income Tax Expense (Benefit) for 2021 was -$671K, a 36.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)